BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23363527)

  • 1. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy.
    Zhang X; Zhang X; Wang S; Liu M; Zhang Y; Tao L; Wei Y
    ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
    Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
    Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
    Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
    Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A facile surface modification strategy for fabrication of fluorescent silica nanoparticles with the aggregation-induced emission dye through surface-initiated cationic ring opening polymerization.
    Huang L; Yang S; Chen J; Tian J; Huang Q; Huang H; Wen Y; Deng F; Zhang X; Wei Y
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():270-278. PubMed ID: 30423709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable mesoporous silica nanoparticles incorporated with MoS2 and AIE for targeted fluorescence imaging and photothermal therapy of cancer cells.
    Wang J; Xu M; Wang K; Chen Z
    Colloids Surf B Biointerfaces; 2019 Feb; 174():324-332. PubMed ID: 30472618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant modification of aggregation-induced emission material as biocompatible nanoparticles: facile preparation and cell imaging.
    Zhang X; Zhang X; Wang S; Liu M; Tao L; Wei Y
    Nanoscale; 2013 Jan; 5(1):147-50. PubMed ID: 23154790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of fluorescent silica nanoparticles with aggregation-induced emission luminogens for cell imaging.
    Chen S; Lam JW; Tang BZ
    Methods Mol Biol; 2013; 991():163-9. PubMed ID: 23546668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
    Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
    Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
    Li X; Xie QR; Zhang J; Xia W; Gu H
    Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles.
    Urata C; Aoyama Y; Tonegawa A; Yamauchi Y; Kuroda K
    Chem Commun (Camb); 2009 Sep; (34):5094-6. PubMed ID: 20448957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic-cationic switchable amphoteric monodisperse mesoporous silica nanoparticles.
    Ma Y; Xing L; Zheng H; Che S
    Langmuir; 2011 Jan; 27(2):517-20. PubMed ID: 21166445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
    Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
    Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-functionalized mesoporous silica nanospheres hybridized with AIE luminogens for targeted cancer cell imaging.
    Wang Z; Xu B; Zhang L; Zhang J; Ma T; Zhang J; Fu X; Tian W
    Nanoscale; 2013 Mar; 5(5):2065-72. PubMed ID: 23376958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.